Truveta Genome Project

The Truveta Genome Project is an ambitious initiative by Truveta aimed at creating the largest and most diverse de-identified database of genotypic and phenotypic information ever assembled. By genetically sequencing tens of millions of de-identified Americans — a scale 10 times larger than any previous endeavor — the project is designed to accelerate drug discovery, optimize clinical trials, and fundamentally transform how diseases are prevented, diagnosed, and cured.

The project is built for researchers, health systems, and life sciences organizations seeking to harness the combined power of genetic and clinical data. By representing the full diversity of the United States across ancestries, ethnicities, and other social drivers of health, the Truveta Genome Project is uniquely positioned to address health inequities and enable truly personalized medicine at population scale.

How the Truveta Genome Project Works

1. Consent: Healthcare sites obtain patient consent to use leftover biospecimens collected during routine lab tests, ensuring ethical participation from the outset.
2. Sequence: Biospecimens are genetically sequenced while preserving patient anonymity. Leftover biospecimens are also stored to support future multi-omics sequencing efforts.
3. Research: De-identified genetic data is linked to de-identified medical records and integrated into Truveta Data, making it available for broad research use.

Key Capabilities and Research Potential

• Unprecedented scale — genetic sequencing of tens of millions of de-identified Americans, far exceeding the scope of any prior genomic database.
• Unmatched diversity representing all US populations across ancestries, ethnicities, and social determinants of health.
• Integration of genomic data with rich clinical and environmental data to uncover how different populations are uniquely affected by their environments.
• Enabling the development of targeted interventions to reduce health disparities and ensure more equitable, personalized patient care.
• Supporting a shift in healthcare from disease treatment to disease prevention through deeper biological understanding.
• Facilitating new discoveries in drug development, clinical trial optimization, and disease biology using advanced AI applied to representative genomic datasets.

Partner Health System Involvement

• Leading health systems, including Northwell Health and CommonSpirit, are active partners in the Truveta Genome Project.
• Partners share the vision of transforming healthcare from reactive disease treatment to proactive disease prevention.
• Health system leaders emphasize the project's potential to revolutionize patient care by combining genomic insights with clinical and environmental data at scale.

The Truveta Genome Project represents a collaborative effort between Truveta, major health systems, and the broader research community. By anonymously linking patient biospecimens to de-identified medical records and making this data available through Truveta Data, the project provides researchers with an unparalleled resource to advance the science of human health, lower the cost of care, and drive meaningful progress toward a more equitable healthcare future.